Compare Onelife Capital with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 2.94% and Operating profit at 9.44%
Negative results in Dec 25
With ROE of -15.9, it has a Very Expensive valuation with a 2.2 Price to Book Value
99.21% of Promoter Shares are Pledged
Stock DNA
Capital Markets
INR 61 Cr (Micro Cap)
NA (Loss Making)
21
0.00%
1.29
-15.86%
2.29
Total Returns (Price + Dividend) 
Onelife Capital for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Onelife Capital Advisors Ltd Hits Lower Circuit Amid Heavy Selling Pressure
Onelife Capital Advisors Ltd (NSE: 525178) plunged to its lower circuit limit on 2 Mar 2026, closing at ₹14.89, down 4.98% from the previous close. The stock faced intense selling pressure, with panic selling and unfilled supply dominating trade, marking a maximum daily loss that outpaced both its sector and the broader market indices.
Read full news article
Onelife Capital Advisors Ltd Downgraded to Strong Sell Amid Financial and Technical Concerns
Onelife Capital Advisors Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 24 Feb 2026, reflecting a deteriorating financial trend and valuation concerns despite some mildly bullish technical signals. The company’s performance across quality, valuation, financial trend, and technical parameters has been carefully analysed, revealing a complex picture that has ultimately led to a cautious stance from analysts.
Read full news article
Onelife Capital Advisors Ltd Hits Upper Circuit Amid Strong Buying Momentum
Onelife Capital Advisors Ltd (NSE: 525178) surged to its upper circuit limit on 17 Feb 2026, closing at ₹16.90, marking a robust 4.51% gain on the day. This rally was driven by intense buying interest, pushing the stock to its maximum daily price band of ₹16.97, signalling strong investor confidence despite a micro-cap market capitalisation of ₹60.90 crores.
Read full news article Announcements 
Board Meeting Outcome for Outcome Of The Right Issue Committee Meeting - Extension Of Rights Issue Closing Date & On Market Renunciation Date.
02-Mar-2026 | Source : BSEPursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Right Issue Committee of the Board of Directors of Onelife Capital Advisors Limited (the Company) at its Meeting held on March 02 2026 has inter alia considered and approved the Further extension of Rights Issue Closing Date & On Market Renunciation Date of the ongoing Rights Issue. The Rights Issue which commenced on Monday February 23 2026 and was earlier scheduled to close on Friday March 06 2026 will now close on Monday March 16 2026 in order to provide a further window of opportunity for eligible equity Shareholders to apply. Further Last Date for On Market Renunciation which was Monday March 02 2026 will now be Tuesday March 10 2026.
Corporate Action-Outcome of Right issue
02-Mar-2026 | Source : BSEOutcome of Right issue Committee meeting for Extension of Issue closing date and last date for on market renunciation
Announcement under Regulation 30 (LODR)-Newspaper Publication
20-Feb-2026 | Source : BSEEnclosed herewith Newspaper Publications relating to Rights Issue of the Company
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Onelife Capital Advisors Ltd has announced 300:167 rights issue, ex-date: 16 Feb 26
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
99.2098
Held by 0 Schemes
Held by 0 FIIs
Naig Prabhakar K (51.68%)
P S Kumaresan (1.57%)
43.49%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -86.79% vs 354.12% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 62.39% vs -786.27% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -45.99% vs 179.49% in Sep 2024
Growth in half year ended Sep 2025 is 18.34% vs -833.33% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -48.06% vs 118.95% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 24.21% vs -665.52% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -69.51% vs 733.33% in Mar 2024
YoY Growth in year ended Mar 2025 is -1,417.95% vs 115.73% in Mar 2024






